Skip to main content

Deal Alert: Matrix Partners India invests in TechMed

Matrix Partners India today announced that it has picked up significant minority stake in TechMed, a Hospital Lab Management (HLM) pathology chain based out of Chennai. TechMed has partnered with hospitals across South India to provide testing services for patients within hospital premises. Each HLM center in the hospital is supported by a proximate state-of-the-art mother center to provide results for a wide array of tests quickly. Dr. T.G. Rajaramanan, a general surgeon, started Techmed in 2009.

“As a budding surgeon, I saw that getting reliable tests quickly at the hospital doorstep is a hassle. In addition, retaining manpower was tough, and training them tougher. Hospitals mostly outsourced high-end tests affecting both commercials and turnaround time. My desire to find a commercial, operationally viable solution led me to the HLM model. Joining hands with Matrix Partners India is an important milestone in our journey”, said Dr. T.G. Rajaramanan, Founder and Managing Director of TechMed

“We found Dr. Rajaramanan's vision inspiring and believe TechMed provides a win-win solution for hospitals and patients alike. Pathology has tremendous growth potential and TechMed’s innovative business model suitably complements our growing healthcare portfolio”, said Asish Mohapatra, Director, Matrix India

TechMed currently has 30 HLM and collection centers across South India and two ‘state-of-the-art’ mother centers to support the HLMs for high-end tests. The chain plans to expand its operations to over 300 centers in South and East India in the next two years, and subsequently a pan India presence. Dr. Wasim Mohideen, Dr. Masood Ikram and Mrs. Mohana Pillai lead operations along with Dr. Rajaramanan in a team full of young, passionate doctors. TechMed is currently ramping up its human capital in both clinical and non-clinical domains. 

About TechMed:

TechMed is an exclusive “Hospital Lab Management” (HLM) pathology chain in South India. Dr. T.G. Rajaramanan started TechMed along with co-founder Dr. Wasim Mohideen in 2009. It aims to provide faster and accurate pathology test results within hospital premises at affordable costs while eliminating operational and commercial hassles for hospital management. Headquartered in Chennai, TechMed has a large network of HLMs that are supported by ‘state-of-the-art’ standalone mother centers (starting with Chennai and Bangalore). Highly trained pathologists and technicians are enabled with technology and efficient operating systems to ensure quick turn around and high quality of reports. TechMed conducts wide array of tests pertaining to pathology, biochemistry, microbiology, immunology, histopathology and hematology. Further information is available at www.techmedhealthcare.com  

About Matrix Partners India: 

Matrix Partners India is an investment firm with INR 3,000 crore under management. The firm invests in companies targeting the Indian consumer market at the seed, early and early growth stages. In healthcare, the firm has invested in several market leading companies/ chains like Centre for Sight (eye care), Cloudnine (maternity and infant care), Mewar Ortho (orthopedic care), Enhance (cosmetology) and Meditrina (interventional cardiology). It has also invested in other leaders like Mswipe (mobile POS), Muthoot Finance (gold loan NBFC), Quikr (online classifieds), TreeHouse Education (preschools), U2opia (social mobile apps), Verse/ NewsHunt (vernacular mobile platform) and W (women’s ethnic wear) among others. Matrix Partners has a global network of funds investing in the US, China and India with US $3 billion under management. Further information is available at www.matrixpartners.in 

Venture Intelligence is the leading provider of data and analysis on Private Company Financials, Transactions (private equity, venture capital and M&A) & their Valuations in India. Click Here to view our products list including the Free Deal Digest Weekly: India's First & Most Exhaustive Transactions Newsletter.

Popular posts from this blog

PE-VC investments decline 8% to $6.2 B in Q1'24

Press Release: Private Equity - Venture Capital (PE-VC) firms invested over $6.2 Billion (across 205 deals) in Indian companies during the first three months of 2024, shows data from  Venture Intelligence , a research service focused on private company financials, transactions, and their valuations. (Note: These figures include Venture Capital type investments, but exclude PE investments in Real Estate). The investment amount represents a 8% fall over the $6.7 Billion (across 242 deals) invested in the same period during 2023 and also down by 6% when compared to the immediate previous quarter (which witnessed $6.6 Billion being invested across 200 deals). Deal volumes in Q1'24 also declined 15% compared to Q1'23 and were up by 3% compared to the immediate previous quarter.  Q1’24 witnessed 8 mega deals ($100 M+ rounds) worth $3.5 Billion, compared to 17 such investments (worth $3.6 Billion) in Q1’23 and 15 such deals (worth $4.1 Billion) in the immediate previous quarter.  Th

PE-VC investments in Q2'23 decline 33% to $9.9 Billion

Private Equity-Venture Capital (PE-VC) investments in India during the quarter ended June 2023 (Q2'23), at $9.85 Billion across 182 deals, registered a 33% decrease compared to the same period in 2022 (which saw $14.6 Billion being invested across 371 deals). The investment amount however rose 74% compared to the immediate previous quarter (which saw $5.7 Billion being invested across 181 deals), shows data from  Venture Intelligence , a research service focused on private company financials, transactions, and their valuations. The PE-VC investment figures for the first 6 months of 2023 - at $15.5 Billion (across 363 deals) - was 50% lower compared to the same period in 2022 (which saw $31 Billion being invested across 800 deals). Q2’23 witnessed 19 mega deals ($100 M+

Chiratae, Speciale and Stride Ventures win APEX'24 Venture Capital Awards

Chiratae Ventures, Speciale Invest and Stride Ventures were awarded as among the leading Venture Capital investors in India for 2023 as part of Venture Intelligence APEX‘24 Private Equity & Venture Capital awards event in Mumbai.  The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms and "crowd sourced" voting from the Limited Partner, PE-VC and advisory communities. (The main criteria are Return Track Record, New Fund Raises & Follow-on Funding Rounds for Portfolio Companies) VC Investor of the Year Chiratae Ventures received the Venture Capital Investor of the Year 2023 Award on the back of 10 part exits totaling $178 million via Secondary Sales during the year. Its exits included those from retail unicorn Lenskart, SaaS Startup Pixis and baby pr

Blackstone, MO Alts and InvAscent win APEX'24 Private Equity Awards

Press Release Blackstone, MO Alternates (formerly Motilal Oswal PE) and InvAscent were awarded as among the leading Private Equity and Growth Capital investors in India for 2023 as part of Venture Intelligence APEX‘24 Private Equity & Venture Capital awards event in Mumbai.  The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms and "crowd sourced" voting from the Limited Partner, PE-VC and advisory communities. (The main criteria are Return Track Record, New Fund Raises & Follow-on Funding Rounds for Portfolio Companies) PE Investor of the Year Blackstone received the Private Equity Investor of the Year 2023 Award on the back of strong complete exits during the year: from Sona Comstar and IBS Software. Ganesh Mani and Amit Dalmia, Senior Managing D

Avendus tops League Table for Transaction Advisors to PE deals in Q1'23

Aeka Advisors and Ambit claim the No.2 & 3 slot Avendus topped the Venture Intelligence League Table for Transaction Advisor to Private Equity Transactions for Q1 2023 advising 5 deals worth $808 million. Aeka Advisors stood second having advised 3 deals worth $228 million. Ambit followed with 4 deals worth $160 million. Ernst & Young ($114 million across 4 deals) and o3 Capital ($80 million across 2 deals) completed the top five for Q1 2023. Avendus acted as advisor to ADIA’s $500 million investment in omnichannel eyewear retailer Lenskart . Aeka Advisors acted as advisor to Kreditbee’s $160 million fundraise from Advent International, Mitsubishi UFJ Financial Group (MUFG) and existing investors. Ambit advised the $104 million fundraise of Freshtohome from Mount Judi Ventures, Iron Pillar, Amazon and others. The  Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on the value of PE